The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Discovery of Leucyladenylate Sulfamates as Novel Leucyl-tRNA Synthetase (LRS)-Targeted Mammalian Target of Rapamycin Complex 1 (mTORC1) Inhibitors
Abstract
Recent studies indicate that LRS may act as a leucine sensor for the mTORC1 pathway, potentially providing an alternative strategy to overcome rapamycin resistance in cancer treatments. In this study, we developed leucyladenylate sulfamate derivatives as LRS-targeted mTORC1 inhibitors. Compound 18 selectively inhibited LRS-mediated mTORC1 activation and exerted specific cytotoxicity against colon cancer cells with a hyperactive mTORC1, suggesting that 18 may offer a novel treatment option for human colorectal cancer.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The leucyl-tRNA synthetase (LRS) has been proposed to function as a leucine sensor for mTORC1, acting as a GAP for RagD, and several recent compounds, e.g. (S)-4-isobutyloxazolidin-2-one and BC-LI-0186, have been identified that inhibit mTORC1 by interfering with LRS sensing or activity 178,183–186.”
From Targeting the biology of aging with mTOR inhibitors (2023) · cites this paper as [183]
Citations
Cites
mTOR and cancer: insights into a complex relationship
Sabatini, D. M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1974 · Cited by 1,322
Research works printed but not linked: 37
- 10.1016/j.cell.2012.03.017 · DOI · Paper page
- 10.1038/nrm2672 · DOI · Paper page
- 10.1126/science.1187532 · DOI
- 10.1016/j.ccr.2010.01.021 · DOI · Paper page
- 10.1038/nrm3025 · DOI · Paper page
- 10.1016/j.tips.2014.11.004 · DOI
- 10.1056/NEJMoa066838 · DOI
- 10.1016/S0140-6736(08)61039-9 · DOI · Paper page
- 10.1200/JCO.2012.45.5766 · DOI · Paper page
- 10.1586/17512433.2013.827397 · DOI
- 10.4161/auto.5.5.8504 · DOI
- 10.1111/j.1753-4887.2007.tb00289.x · DOI
- 10.1152/ajpendo.00525.2011 · DOI
- 10.1016/j.cell.2012.02.044 · DOI · Paper page
- 10.1016/j.molcel.2012.02.009 · DOI
- 10.1002/emmm.201100626 · DOI
- 10.1021/acschembio.5b00291 · DOI
- 10.1128/AAC.01339-16 · DOI
- 10.1128/AAC.00820-16 · DOI
- 10.1073/pnas.0802862105 · DOI
- 10.1038/nchembio.1381 · DOI
- 10.1039/C5OB00791G · DOI
- 10.1002/(SICI)1097-4644(20000501)77:2<234::AID-JCB7>3.0.CO;2-I · DOI
- 10.1074/jbc.M803348200 · DOI
- 10.1016/j.bmcl.2016.05.011 · DOI · Paper page
- 10.1016/j.bmc.2004.09.055 · DOI
- 10.1016/S0960-894X(00)00360-7 · DOI
- 10.1016/S0960-894X(03)00020-9 · DOI
- 10.1016/j.bmcl.2005.05.035 · DOI
- 10.1016/j.ejmech.2015.02.010 · DOI
- 10.1021/ml2000615 · DOI
- 10.1016/S0040-4039(98)00888-0 · DOI
- 10.1093/nar/gkm169 · DOI
- 10.1038/nprot.2006.179 · DOI
- 10.3748/wjg.v20.i15.4178 · DOI
- 10.18632/oncotarget.1548 · DOI
- 10.1002/ejoc.201300699 · DOI
Cited by
Sorted by citations
Targeting the biology of aging with mTOR inhibitors
Mannick, J. B., & Lamming, D. W. (2023) · Nature Aging · doi:10.1038/s43587-023-00416-y · Cited by 372
Metadata
- Authors
- Yoon, S., Kim, J. H., Kim, S.-E., Kim, C., Tran, P.-T., Ann, J., Koh, Y., Jang, J., Kim, S., Moon, H.-S., Kim, W. K., Lee, S., Lee, J., Kim, S., & Lee, J.
- Affiliations
- Research Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, Seoul 151-742, Korea
- Medicinal Bioconvergence Research Center, College of Pharmacy, Seoul National University, Seoul 151-742, Korea
- Department of Global Medical Science, Sungshin University, Seoul 142-732, Korea
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2016-11-09
- Volume
- 59
- Issue
- 22
- Pages
- 10322-10328
- ISSN
- 0022-2623
- 1520-4804
- Cited by
- 17
- References
- 1
- Language
- en
- Funders
- National Research Foundation of Korea (NRF-2012M3A6A4054928)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review